Before the Senate's confirmation vote on President Donald Trump’s pick for secretary of the Department of Health and Human ...

While much of Valneva's focus these days is centered on its landmark vaccine for chikungunya virus, the French immunization ...

Among its various international efforts, USAID works to strengthen global supply chains and promote access to essential ...

When it comes to the safe use of synthetic opioids like fentanyl, precise dosing of the powerful pain meds is key. Now, ...

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in ...

“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...

Novartis has become the latest drugmaker to get in trouble over an employee’s LinkedIn likes. The U.K. | Novartis has become ...

Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...

The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...

One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...

AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the ‘they won’t’ camp ...